Healthcare -
Biotechnology - NASDAQ - US
$ 1.63
3.82 %
$ 248 M
Market Cap
-10.19
P/E
HRTX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss HRTX - Heron Therapeutics, Inc.
13 K
LAST VALUE
104.12%
2 YEAR CAGR
16.54%
5 YEAR CAGR
7.19%
10 YEAR CAGR